Important Notice to Long-Term Shareholders of Five9, Inc. (NASDAQ: FIVN); Integer Holdings Corp. (NYSE: ITGR); Kyndryl Holdings (NYSE: KD); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
PHILADELPHIA, Feb. 27, 2026 (GLOBE NEWSWIRE) --
Five9 (NASDAQ: FIVN) – Securities Fraud Class Action Survives Motion to Dismiss:
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of long-term Five9, Inc. (NASDAQ: FIVN) shareholders as an underlying securities fraud class action complaint has survived a motion to dismiss. The investigation concerns whether certain officers of the company have breached their fiduciary duties they owed to the company.
If you have held Five9 (NASDAQ: FIVN) shares continuously since prior to June 4, 2024, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever. Visit https://grabarlaw.com/the-latest/five9-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.
WHY? A federal securities fraud class action that was filed against Five9 and two of its Officers has now survived a motion to dismiss. That Complaint alleges that Five9 (NASDAQ: FIVN), through certain of its officers, misrepresented the purported strength of the Company's net new business bookings and visibility into its installed customer base, and that when these statements were made, Five9 was in the throes of a “challenging bookings quarter” due to constrained and scrutinized customer budgets and sales execution issues, forcing the Company to cut its annual revenue guidance and take remedial action to address sales execution issues.
On February 23, 2026, a federal court determined, among other things, that “plaintiffs allege with particularity that defendants knew, and failed to disclose, that Five9 was performing below its own projections and expectations in the first half of 2024.” Evidence presented was deemed sufficient for plaintiffs to plead that certain of Defendants’ statements about the strength of Five9’s sales, including that “the net new side of our business is very strong” and “we are seeing very strong bookings momentum on the net new side,” were false or misleading, and plaintiffs alleged with particularity that defendants’ June 2024 statements about macro factors were false or misleading. Plaintiffs further established a strong inference of deliberate recklessness or intent to deceive with respect to certain false and misleading statements.
WHAT CAN YOU DO NOW? If you have held Five9 (NASDAQ: FIVN) shares continuously since before June 4, 2024, you are encouraged to visit https://grabarlaw.com/the-latest/five9-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com or call 267-507-6085. You can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever.
#FIVN $FIVN #Five9
Integer Holdings Corp. (NYSE: ITGR):
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings Corp. (NYSE: ITGR). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased Integer Holdings Corp. (NYSE: ITGR), shares prior to July 25, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. You are encouraged to visit https://grabarlaw.com/the-latest/integer-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.
WHY? As alleged in a recently filed federal securities fraud class action complaint, Integer Holdings Corp. (NYSE: ITGR), through certain of its officers, made materially false and/or misleading and failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, it is alleged that the Company failed to disclose that: (1) Integer materially overstated its competitive position within the growing EP manufacturing market; (2) despite Integer’s claims of strong visibility into customer demand, the Company was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth driver for the Company’s C&V segment; and (4) as a result of the above, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
WHAT CAN YOU DO NOW? If you purchased Integer Holdings Corp. (NYSE: ITGR), shares prior to July 25, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/integer-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.
#ITGR $ITGR #IntegerHoldings
Kyndryl Holdings, Inc. (NYSE: KD):
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Kyndryl Holdings, Inc. (NYSE: KD). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased Kyndryl Holdings (NYSE: KD) shares prior to August 7, 2024, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/kyndryl-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to lear more.
WHY? According to a recently filed federal securities fraud class action lawsuit, on February 9, 2026, Kyndryl Holdings announced that it was unable to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025, that the Securities and Exchange Commission was investigating the Company's cash management practices and disclosures, that the Audit Committee of the Board of Directors was reviewing those issues internally, that the Company anticipated reporting material weaknesses in internal controls with respect to information and communication, as well as tone at the top.
WHAT YOU CAN DO NOW: If you purchased Kyndryl Holdings (NYSE: KD) shares prior to August 7, 2024, you are encouraged to visit https://grabarlaw.com/the-latest/kyndryl-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.
#Kyndryl #KD $KD
Molina Healthcare, Inc. (NYSE: MOH):
WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Molina Healthcare, Inc. (NYSE: MOH). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased Molina Healthcare, Inc. (NYSE: MOH), shares prior to February 5, 2025 and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/molina-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.
WHY? As alleged in an underlying securities fraud class action complaint, Molina Healthcare, Inc. (NYSE: MOH), through certain of its officers, failed to disclose: (1) material, adverse facts concerning Molina Healthcare's "medical cost trend assumptions"; (2) that Molina Healthcare was experiencing a "dislocation between premium rates and medical cost trend"; (3) that Molina Healthcare's near term growth was dependent on a lack of "utilization of behavioral health, pharmacy, and inpatient and outpatient services"; and (4) as a result, Molina Healthcare's financial guidance for fiscal year 2025 was substantially likely to be cut.
WHAT YOU CAN DO NOW: If you purchased Molina Healthcare, Inc. (NYSE: MOH), shares prior to February 5, 2025 and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/molina-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. $MOH #Molina #MOH
Attorney Advertising Disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
